Polycyclic Tetramate Macrolactams and Their Potential as Anticancer Agents

References (45)

1. 1 Demain, 2014, Importance of microbial natural products and the need to revitalize their discovery [DOI]
2. 2 David, 2015, The pharmaceutical industry and natural products: Historical status and new trends [DOI]
3. 3 Atanasov, 2021, Natural products in drug discovery: Advances and opportunities [DOI]
4. 4 Siegel, 2024, Cancer statistics, 2024 [DOI]
5. 5 Sun, 2023, Targeting GDP-Dissociation Inhibitor Beta (GDI2) with a Benzo[a]quinolizidine Library to Induce Paraptosis for Cancer Therapy [DOI]
6. 6 Huang, 2021, Natural Products in Cancer Therapy: Past, Present and Future [DOI]
7. 7 Zheng, 2016, Novel Benzo[a]quinolizidine Analogs Induce Cancer Cell Death through Paraptosis and Apoptosis [DOI]
8. 8 Wang, H., He, Y., Jian, M., Fu, X., Cheng, Y., He, Y., Fang, J., Li, L., and Zhang, D. (2022). Breaking the Bottleneck in Anticancer Drug Development: Efficient Utilization of Synthetic Biology. Molecules, 27. [DOI]
9. 9 Surade, 2012, Structural biology and drug discovery of difficult targets: The limits of ligandability [DOI]
10. 10 Mallinson, 2012, Macrocycles in new drug discovery [DOI]
11. 11 Liu, W., Zhang, W., Jin, H., Zhang, Q., Chen, Y., Jiang, X., Zhang, G., Zhang, L., Zhang, W., and She, Z. (2019). Genome Mining of Marine-Derived Streptomyces sp. SCSIO 40010 Leads to Cytotoxic New Polycyclic Tetramate Macrolactams. Mar. Drugs, 17. [DOI]
12. 12 Blodgett, 2010, Common biosynthetic origins for polycyclic tetramate macrolactams from phylogenetically diverse bacteria [DOI]
13. 13 Luo, 2013, Activation and characterization of a cryptic polycyclic tetramate macrolactam biosynthetic gene cluster [DOI]
14. 14 Medema, 2021, Mining genomes to illuminate the specialized chemistry of life [DOI]
15. 15 Ding, W., Tu, J., Zhang, H., Wei, X., Ju, J., and Li, Q. (2021). Genome Mining and Metabolic Profiling Uncover Polycyclic Tetramate Macrolactams from Streptomyces koyangensis SCSIO 5802. Mar. Drugs, 19. [DOI]
16. 16 Mo, 2014, Naturally occurring tetramic acid products: Isolation, structure elucidation and biological activity [DOI]
17. 17 Lowery, 2009, Defining the mode of action of tetramic acid antibacterials derived from Pseudomonas aeruginosa quorum sensing signals [DOI]
18. 18 Bodenschatz, 2022, A synthetic approach to 5/5/6-polycyclic tetramate macrolactams of the discodermide type [DOI]
19. 19 Xu, 2015, Bioactive Polycyclic Tetramate Macrolactams from Lysobacter enzymogenes and Their Absolute Configurations by Theoretical ECD Calculations [DOI]
20. 20 Saha, 2017, Activation and characterization of a cryptic gene cluster reveals a cyclization cascade for polycyclic tetramate macrolactams [DOI]
21. 21 Jin, 2020, Engineered Biosynthesis of 5/5/6 Type Polycyclic Tetramate Macrolactams in an Ikarugamycin (5/6/5 Type)-Producing Chassis [DOI]
22. 22 Li, 2018, Biosynthesis of the Polycyclic System in the Antifungal HSAF and Analogues from Lysobacter enzymogenes [DOI]
23. 23 Li, 2019, OX4 Is an NADPH-Dependent Dehydrogenase Catalyzing an Extended Michael Addition Reaction to Form the Six-Membered Ring in the Antifungal HSAF [DOI]
24. 24 Harper, C.P., Day, A., Tsingos, M., Ding, E., Zeng, E., Stumpf, S.D., Qi, Y., Robinson, A., Greif, J., and Blodgett, J.A.V. (2024). Critical analysis of polycyclic tetramate macrolactam biosynthetic gene cluster phylogeny and functional diversity. Appl. Environ. Microbiol., 90. [DOI]
25. 25 Yan, 2021, Combinatorial Biosynthesis of Oxidized Combamides Using Cytochrome P450 Enzymes from Different Polycyclic Tetramate Macrolactam Pathways [DOI]
26. 26 Jiang, 2023, A Mechanistic Understanding of the Distinct Regio- and Chemoselectivity of Multifunctional P450s by Structural Comparison of IkaD and CftA Complexed with Common Substrates [DOI]
27. 27 DeVita, 2012, Two hundred years of cancer research [DOI]
28. 28 Sullivan, 2015, Global cancer surgery: Delivering safe, affordable, and timely cancer surgery [DOI]
29. 29 Craver, 1952, Recent advances in treatment of inoperable cancer
30. 30 Aoki, 2000, Melophlins A and B, novel tetramic acids reversing the phenotype of ras-transformed cells, from the marine sponge Melophlus sarassinorum [DOI]
31. 31 Birnie, 1988, The HL60 cell line: A model system for studying human myeloid cell differentiation
32. 32 Li, 2023, Discovery and biosynthesis of pseudoamides reveal enzymatic cyclization of the polyene precursor to 5–5 bicyclic tetramate macrolactams [DOI]
33. 33 Chen, 2024, Discovery of Aburatubolactams Reveals Biosynthetic Logic for Distinct 5/5-Type Polycyclic Tetramate Macrolactams [DOI]
34. 34 Dhaneesha, 2019, DNA Binding and Molecular Dynamic Studies of Polycyclic Tetramate Macrolactams (PTM) with Potential Anticancer Activity Isolated from a Sponge-Associated Streptomyces zhaozhouensis subsp. mycale subsp. nov [DOI]
35. 35 Khoo, 1988, Enhanced macrophage uptake of low density lipoprotein after self-aggregation [DOI]
36. 36 Gui, Y., Zheng, H., and Cao, R.Y. (2022). Foam Cells in Atherosclerosis: Novel Insights into Its Origins, Consequences, and Molecular Mechanisms. Front. Cardiovasc. Med., 9. [DOI]
37. 37 Poznyak, A.V., Nikiforov, N.G., Markin, A.M., Kashirskikh, D.A., Myasoedova, V.A., Gerasimova, E.V., and Orekhov, A.N. (2021). Overview of OxLDL and its impact on cardiovascular health: Focus on atherosclerosis. Front. Pharmacol., 11. [DOI]
38. 38 Hasumi, 1992, Inhibition of the uptake of oxidized low-density lipoprotein in macrophage J774 by the antibiotic ikarugamycin [DOI]
39. 39 Elkin, 2016, Ikarugamycin: A Natural Product Inhibitor of Clathrin-Mediated Endocytosis [DOI]
40. 40 Motley, 2003, Clathrin-mediated endocytosis in AP-2-depleted cells [DOI]
41. 41 Luo, 2001, Human immunodeficiency virus type 1 Nef-induced CD4 cell surface downregulation is inhibited by ikarugamycin [DOI]
42. 42 Popescu, 2011, Ikarugamycin induces DNA damage, intracellular calcium increase, p38 MAP kinase activation and apoptosis in HL-60 human promyelocytic leukemia cells [DOI]
43. 43 Bertasso, 2020, Ripromycin and other polycyclic macrolactams from Streptomyces sp. Tu 6239: Taxonomy, fermentation, isolation and biological properties [DOI]
44. 44 Jiang, 2020, Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2
45. 45 Minamidate, A., Onizawa, M., Saito, C., Hikichi, R., Mochimaru, T., Murakami, M., Sakuma, C., Asakawa, T., Hiraoka, Y., and Oshima, S. (2021). A potent endocytosis inhibitor Ikarugamycin up-regulates TNF production. Biochem. Biophys. Rep., 27. [DOI]

Cited by 4

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Related research

• HPTLC Densitogram Profile of Aqueous Distillate (Arka) from Roots of Boerhaavia diffusa — shares topic coverage
• Effects of Ethanol Extract of Unripe Annona muricata (l.) Fruits on the Haematological and Histopathological Parameters in Swiss Albino Rats Infected with Salmonella typhi — shares topic coverage
• In vitro Efficacies of Some Nigerian Medicinal Plant Extracts against Toxigenic Aspergillus flavus, A. parasiticus and A. ochraceus — shares topic coverage
• Molecular Mechanisms of the Modulatory Effect of Vitamin E on Tacrolimus (FK506)-Induced Renal Injury in Rats — shares topic coverage
• Evaluation of the Physicochemical and in vitro Dissolution Properties of Metformin Hydrochloride Tablet Brands Marketed in Five Cities in Ghana — shares topic coverage